Bridging therapy and risk of major bleeding and thrombosis in continuous-flow left ventricular assist device patients: a quasi-experimental study

Back

ESC Professional Premium Access

Bridging therapy and risk of major bleeding and thrombosis in continuous-flow left ventricular assist device patients: a quasi-experimental study

Session: Challenges and opportunities in heart transplantation and ventricular assist devices

Topic: Ventricular Assist Devices

Speaker: Mr R. Roovers (Leiden, NL)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Mr Robin Roovers

Leiden University Medical Center, Leiden (Netherlands (The))

0 follower

5 more presentations in this session

Non-HLA autoantibodies supplement donor specific antibodies in predicting graft survival after heart transplantation

Speaker: Doctor G. Oh (Seoul, KR)

Role of NTproBNP and donor-derived cell-free DNA in the diagnosis of acute rejection in heart transplant recipients: a prospective study

Speaker: Doctor M. Jimenez-Blanco Bravo (Madrid, ES)

Urinary proteomics signature of malignancy post heart transplantation is associated with mortality risk

Speaker: Doctor Z. Zhang (Leuven, BE)

Transcatheter edge to edge repair of functional mitral regurgitation as bridge to heart transplantation: 2-years follow up results from MitraBridge international registry

Speaker: Doctor C. Marcelli (Bologna, IT)

Transition from temporary microaxial left ventricular assist devices to durable mechanical circulatory support systems

Speaker: Mr D. Lewin (Berlin, DE)

Access the full session

Challenges and opportunities in heart transplantation and ventricular assist devices

Speakers: Mr R. Roovers, Doctor G. Oh, Doctor M. Jimenez-Blanco Bravo, Doctor Z. Zhang, Doctor C. Marcelli...

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources